James Investment Research’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $712K | Sell |
2,477
-184
| -7% | -$52.9K | 0.08% | 180 |
|
|
2025
Q1 | $820K | Sell |
2,661
-4
| -0.2% | -$1.23K | 0.1% | 167 |
|
|
2024
Q4 | $940K | Sell |
2,665
-144
| -5% | -$50.8K | 0.11% | 155 |
|
|
2024
Q3 | $1.01M | Buy |
2,809
+5
| +0.2% | +$1.79K | 0.12% | 161 |
|
|
2024
Q2 | $893K | Sell |
2,804
-19
| -0.7% | -$6.05K | 0.11% | 161 |
|
|
2024
Q1 | $649K | Sell |
2,823
-49
| -2% | -$11.3K | 0.08% | 185 |
|
|
2023
Q4 | $632K | Sell |
2,872
-11
| -0.4% | -$2.42K | 0.08% | 183 |
|
|
2023
Q3 | $651K | Buy |
+2,883
| New | +$651K | 0.09% | 167 |
|
|
2023
Q2 | – | Sell |
-468
| Closed | -$105K | – | 525 |
|
|
2023
Q1 | $105K | Buy |
468
+250
| +115% | +$56.1K | 0.01% | 301 |
|
|
2022
Q4 | $61K | Sell |
218
-51
| -19% | -$14.3K | 0.01% | 340 |
|
|
2022
Q3 | $56K | Buy |
269
+180
| +202% | +$37.5K | 0.01% | 351 |
|
|
2022
Q2 | $21K | Buy |
+89
| New | +$21K | ﹤0.01% | 424 |
|
|
2022
Q1 | – | Sell |
-188
| Closed | -$41K | – | 550 |
|
|
2021
Q4 | $41K | Buy |
+188
| New | +$41K | ﹤0.01% | 391 |
|
|
2019
Q2 | – | Sell |
-1,989
| Closed | -$233K | – | 798 |
|
|
2019
Q1 | $233K | Sell |
1,989
-30
| -1% | -$3.51K | 0.02% | 512 |
|
|
2018
Q4 | $220K | Sell |
2,019
-16,611
| -89% | -$1.81M | 0.01% | 528 |
|
|
2018
Q3 | $2.38M | Sell |
18,630
-2,797
| -13% | -$358K | 0.1% | 212 |
|
|
2018
Q2 | $2.43M | Buy |
+21,427
| New | +$2.43M | 0.09% | 234 |
|
|
2014
Q2 | – | Sell |
-4,200
| Closed | -$395K | – | 531 |
|
|
2014
Q1 | $395K | Sell |
4,200
-52,430
| -93% | -$4.93M | 0.01% | 288 |
|
|
2013
Q4 | $6.4M | Buy |
56,630
+14,670
| +35% | +$1.66M | 0.2% | 118 |
|
|
2013
Q3 | $3.31M | Buy |
41,960
+17,393
| +71% | +$1.37M | 0.13% | 146 |
|
|
2013
Q2 | $1.62M | Buy |
+24,567
| New | +$1.62M | 0.07% | 170 |
|